Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 12, 2012, Pages 1926-1939

  Dedes, P G ^a   Gialeli, Ch ^a,d   Tsonis, A I ^a   Kanakis, I ^a   Theocharis, A D ^a   Kletsas, D ^b   Tzanakakis, G N ^c   Karamanos, N K ^a,d  

^a UNIVERSITY OF PATRAS   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

^d INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

Author keywords

Adhesion; Breast cancer; Extracellular matrix; Invasion; Migration; Zoledronate

Indexed keywords

GELATINASE A; GELATINASE B; GLYPICAN 1; INTEGRIN; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; PROTEOHEPARAN SULFATE; SCLEROPROTEIN; SYNDECAN 1; SYNDECAN 2; SYNDECAN 4; ZOLEDRONIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

BLOTTING, WESTERN; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; DIPHOSPHONATES; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMIDAZOLES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; WOUND HEALING;

EID: 84866675225     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.07.013     Document Type: Article

References (80)

1. K.C. Chu, R.E. Tarone, L.G. Kessler, L.G. Ries, B.F. Hankey, B.A. Miller, and B.K. Edwards Recent trends in US breast cancer incidence, survival, and mortality rates J. Natl. Cancer Inst. 88 1996 1571 1579
2. S. Mook, L.J. Van 't Veer, E.J. Rutgers, P.M. Ravdin, A.O. van de Velde, F.E. van Leeuwen, O. Visser, and M.K. Schmidt Independent prognostic value of screen detection in invasive breast cancer J. Natl. Cancer Inst. 103 2011 585 597
3. T.A. Guise Molecular mechanisms of osteolytic bone metastases Cancer 88 2000 2892 2898
4. L.A. Liotta, and E.C. Kohn The microenvironment of the tumour-host interface Nature 411 2001 375 379
5. Ch. Gialeli, A.D. Theocharis, and N.K. Karamanos Matrix metalloproteinases in health and disease: roles in cancer progression and their pharmacological targeting FEBS J. 278 2011 16 27
6. A.D. Theocharis, S.S. Skandalis, G.N. Tzanakakis, and N.K. Karamanos Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting FEBS J. 277 2010 3904 3923
7. B.P. Toole Hyaluronan promotes the malignant phenotype Glycobiology 12 2002 37 42
8. S. Jothy CD44 and its partners in metastasis Clin. Exp. Metastasis 20 2003 195 201
9. A. Afify, P. Purnell, and L. Nguyen Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion Exp. Mol. Pathol. 86 2009 95 100
10. M.A. Simpson, C.M. Wilson, L.T. Furcht, A.P. Spicer, T.R. Oegema, and J.B. McCarthy Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells J. Biol. Chem. 277 2002 10050 10057
11. J.E. Draffin, S. McFarlane, A. Hill, P.G. Johnston, and D.J. Waugh CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells Cancer Res. 64 2004 5702 5711
12. S. Shin, L. Wolgamott, and S.O. Yoon Integrin trafficking and tumor progression Int. J. Cell Biol. 2012 2012 516 789
13. Y. Zhao, R. Bachelier, I. Treilleux, P. Pujuguet, O. Peyruchaud, P. Clément-Lacroix, and P. Clézardin Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases Cancer Res. 67 2007 5821 5830
14. P. Clëzardin Integrins in bone metastasis formation and potential therapeutic implications Curr. Cancer Drug Targets 9 2009 801 806
15. K. Brew, and H. Nagase The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity Biochim. Biophys. Acta 1803 2010 55 71
16. B. Petrut, M. Trinkaus, C. Simmons, and M. Clemons A primer of bone metastases management in breast cancer patients Curr. Oncol. 15 2008 50 57
17. V.T. Labropoulou, A.D. Theocharis, A. Symeonidis, S.S. Skandalis, N.K. Karamanos, and H.P. Kalofonos Pathophysiology and pharmacological targeting of tumor-induced bone disease: current status and emerging therapeutic interventions Curr. Med. Chem. 18 2011 1584 1598
18. J.R. Green Preclinical pharmacology of zoledronic acid Semin. Oncol. 29 2002 3 11
19. A.J. Roelofs, K. Thompson, S. Gordon, and M.J. Rogers Molecular mechanisms of action of bisphosphonates: current status Clin. Cancer Res. 12 2006 6222 6230
20. R. Coleman Potential use of bisphosphonates in the prevention of metastases in early-stage breast cancer Clin. Breast Cancer 7 2007 29 35
21. G. Morgan, and A. Lipton Antitumor effects and anticancer applications of bisphosphonates Semin. Oncol. 37 2010 30 40
22. R.E. Coleman, M.C. Winter, D. Cameron, R. Bell, D. Dodwell, M.M. Keane, M. Gil, D. Ritchie, J.L. Passos-Coelho, D. Wheatley, R. Burkinshaw, S.J. Marshall, and H. Thorpe The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer Br. J. Cancer 102 2010 1099 1105
23. K. Zarogoulidis, E. Boutsikou, P. Zarogoulidis, E. Eleftheriadou, T. Kontakiotis, H. Lithoxopoulou, G. Tzanakakis, I. Kanakis, and N.K. Karamanos The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis Int. J. Cancer 125 2009 1705 1709
24. V. Gioni, T. Karampinas, G. Voutsinas, A.E. Roussidis, S. Papadopoulos, N.K. Karamanos, and D. Kletsas Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts Mol. Cancer Res. 6 2008 706 714
25. M.C. Winter, I. Holen, and R.E. Coleman Exploring the antitumour activity of bisphosphonates in early breast cancer Cancer Treat. Rev. 34 2008 453 475
26. C. Denoyelle, L. Hong, J.-P. Vannier, J. Soria, and C. Soria New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects Br. J. Cancer 88 2003 1631 1640
27. M. Barbareschi, P. Maisonneuve, D. Aldovini, M.G. Cangi, L. Pecciarini, F. Angelo Mauri, S. Veronese, O. Caffo, A. Lucenti, P.D. Palma, E. Galligioni, and C. Doglioni High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis Cancer 98 2003 474 483
28. J.R. Couchman Transmembrane signaling proteoglycans Annu. Rev. Cell Dev. Biol. 26 2010 89 114
29. K. Matsuda, H. Maruyama, F. Guo, J. Kleeff, J. Itakura, Y. Matsumoto, A.D. Lander, and M. Korc Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells Cancer Res. 61 2001 5562 5569
30. O.C. Kousidou, A. Berdiaki, D. Kletsas, A. Zafiropoulos, A.D. Theocharis, G.N. Tzanakakis, and N.K. Karamanos Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells Mol. Oncol. 2 2008 223 232
31. C.Y. Fears, and A. Woods The role of syndecans in disease and wound healing Matrix Biol. 25 2006 443 456
32. M. Götte, and G.W. Yip Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective Cancer Res. 66 2006 10233 10237
33. S. Misra, P. Heldin, V.C. Hascall, N.K. Karamanos, S.S. Skandalis, R.R. Markwald, and S. Ghatak Hyaluronan-CD44 interactions as potential targets for cancer therapy FEBS J. 278 2011 1429 1443
34. L. Udabage, G.R. Brownlee, S.K. Nilsson, and T.J. Brown The over-expression of HAS2, Hyal-2, and CD44 is implicated in the invasiveness of breast cancer Exp. Cell Res. 310 2005 205 217
35. E.K. Sloan, N. Pouliot, K.L. Stanley, J. Chia, J.M. Moseley, D.K. Hards, and R.L. Anderson Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone Breast Cancer Res. 8 2 2006 R20
36. T.N. Mitropoulou, G.N. Tzanakakis, D. Kletsas, H.P. Kalofonos, and N.K. Karamanos Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells Int. J. Cancer 104 2003 155 160
37. A.E. Roussidis, T.N. Mitropoulou, A.D. Theocharis, C. Kiamouris, S. Papadopoulos, D. Kletsas, and N.K. Karamanos STI571 as a potent inhibitor of growth and invasiveness of human epithelial breast cancer cells Anticancer. Res. 24 2004 1445 1447
38. K. Hotary, E. Allen, A. Punturieri, I. Yana, and S.J. Weiss Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3 J. Cell Biol. 149 2000 1309 1323
39. O.C. Kousidou, A.E. Roussidis, A.D. Theocharis, and N.K. Karamanos Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential Anticancer. Res. 24 2004 4025 4030
40. G. Murphy, and H. Nagase Localizing matrix metalloproteinase activities in the pericellular environment FEBS J. 278 2011 2 15
41. R.W. Tilghman, C.R. Cowan, J.D. Mih, Y. Koryakina, D. Gioeli, J.K. Slack-Davis, B.R. Blackman, D.J. Tschumperlin, and J.T. Parsons Matrix rigidity regulates cancer cell growth and cellular phenotype PLoS One 5 2010 e12905
42. R.E. Coleman Risks and benefits of bisphosphonates Br. J. Cancer 98 2008 1736 1740
43. S.G. Senaratne, G. Pirianov, J.L. Mansi, T.R. Arnett, and K.W. Colston Bisphosphonates induce apoptosis in human breast cancer cell lines Br. J. Cancer 82 2000 1459 1468
44. E. Corey, L.G. Brown, J.E. Quinn, M. Poot, M.P. Roudier, C.S. Higano, and R.L. Vessella Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer Clin. Cancer Res. 9 2003 295 306
45. U. Haus, R. Ebert, J. Meissner-Weigl, S. Zeck, L. Klein-Hitpass, T.D. Rachner, P. Benad, A. Athari, L. Hofbauer, and F. Jakob Effect of zoledronic acid exposure on Ki-67 expression and proliferation in MCF7 cells resistant to apoptosis induction J. Clin. Oncol. 29 Suppl.; abstr e21129 2009
46. L. Insalaco, F. Di Gaudio, M. Terrasi, V. Amodeo, S. Caruso, L.R. Corsini, D. Fanale, N. Margarese, D. Santini, V. Bazan, and A. Russo Analysis of molecular mechanisms and anti-tumoral effects of zoledronic acid in breast cancer cells J. Cell Mol. Med. 2012 10.1111/j.1582-4934.2012.01527.x
47. R.V. Iozzo, and N.Κ. Karamanos Proteoglycans in health and disease: emerging concepts and future directions FEBS J. 277 2010 3863
48. H. Nagase, and N.Κ. Karamanos Metalloproteinases in health and disease: challenges and the future prospects FEBS J. 278 2011 1
49. V. Hascall, and N.Κ. Karamanos Regulatory roles of hyaluronan in health and disease FEBS J. 278 2011 1411
50. A. Bellancene, and V. Castronovo Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases Bull. Cancer 84 1987 17 24
51. Z.-D. Shi, H. Wang, and J.M. Tarbell Heparan sulfate proteoglycans mediate interstitial flow mechanotransduction regulating MMP-13 expression and cell motility via FAK-ERK in 3D collagen PLoS One 6 2011 e15956
52. P. Chen, L.E. Abacherli, S.T. Nadler, Y. Wang, Q. Li, and W.C. Parks MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting α2β1 integrin activation PLoS One 4 2009 e6565
53. J. Tímár, K. Lapis, J. Dudás, A. Sebestyén, L. Kopper, and I. Kovalszky Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer Semin. Cancer Biol. 12 2002 173 186
54. I. Pecheur, O. Peyruchaud, C.M. Serre, J. Guglielmi, C. Voland, F. Bourre, C. Margue, M. Cohen-Solal, A. Buffet, N. Kieffer, and P. Clézardin Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone FASEB J. 16 2002 1266 1268
55. R.D. Sanderson, Y. Yang, L.J. Suva, and T. Kelly Heparan sulfate proteoglycans and heparanase - partners in osteolytic tumor growth and metastasis Matrix Biol. 23 2004 341 352
56. F. Zong, E. Fthenou, F. Mundt, T. Szatmári, I. Kovalszky, L. Szilák, D. Brodin, G. Tzanakakis, A. Hjerpe, and K. Dobra Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration PLoS 6 2011 e14816
57. A. Woods, and J.R. Couchman Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component Mol. Biol. Cell 5 1994 183 192
58. A. Woods, and J.R. Couchman Syndecan 4 and focal adhesion function Curr. Opin. Cell Biol. 13 2001 578 583
59. A.C. Rapraeger Syndecan-regulated receptor signaling J. Cell Biol. 149 2000 995 998
60. A. Woods, R.L. Longley, S. Tumova, and J.R. Couchman Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts Arch. Biochem. Biophys. 374 2000 66 72
61. L.A. Cary, J.F. Chang, and J.L. Guan Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn J. Cell Sci. 109 1996 1787 1794
62. A. Horowitz, E. Tkachenko, and M. Simons Fibroblast growth factor-specific modulation of cellular response by syndecan-4 J. Cell Biol. 157 2002 715 725
63. G. Chalkiadaki, D. Nikitovic, A. Berdiaki, M. Sifaki, K. Krasagakis, P. Katonis, N.K. Karamanos, and G.N. Tzanakakis Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism Int. J. Biochem. Cell Biol. 41 2009 1323 1331
64. R.L. Longley, A. Woods, A. Fleetwood, G.J. Cowling, J.T. Gallagher, and J.R. Couchman Control of morphology, cytoskeleton and migration by syndecan-4 J. Cell Sci. 112 1999 3421 3431
65. P. Auvinen, R. Tammi, J. Parkkinen, M. Tammi, U. Ågren, R. Johansson, P. Hirvikoski, M. Eskelinen, and V.M. Kosma Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival Am. J. Pathol. 156 2000 529 536
66. L.Y. Bourguignon, Z. Gunja-Smith, N. Iida, H.B. Zhu, L.J. Young, W.J. Muller, and R.D. Cardiff CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells J. Cell. Physiol. 176 1998 206 215
67. Q. Yu, and I. Stamenkovic Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis Genes Dev. 14 2000 163 176
68. A. Hill, S. McFarlane, P.G. Johnston, and D.J.J. Waugh The emerging role of CD44 in regulating skeletal micrometastasis Cancer Lett. 237 2006 1 9
69. S.M. Albelda, and C.A. Buck Integrins and other cell adhesion molecules FASEB J. 11 1990 2868 2880
70. M. Rolli, E. Fransvea, J. Pilch, A. Saven, and B. Felding-Habermann Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 9482 9487
71. T. Tarui, N. Andronicos, R.P. Czekay, A.P. Mazar, K. Bdeir, G.C. Parry, A. Kuo, D.J. Loskutoff, D.B. Cines, and Y. Takada Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling J. Biol. Chem. 278 2003 29863 29872
72. J.D. Humphries, A. Byron, and M.J. Humphries Integrin ligands at a glance J. Cell Sci. 119 2006 3901 3903
73. C.G. Knight, L.F. Morton, A.R. Peachey, D.S. Tuckwell, R.W. Farndale, and M.J. Barnes The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens J. Biol. Chem. 275 2000 35 40
74. Y. Kang, P.M. Siegel, W. Shu, M. Drobnjak, S.M. Kakonen, C. Cordón-Cardo, T.A. Guise, and J. Massagué A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 2003 537 549
75. S.M. Eck, P.J. Hoopes, B.L. Petrella, C.I. Coon, and C.E. Brinckerhoff Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model Breast Cancer Res. Treat. 116 2009 79 90
76. F. Wang, S. Reierstad, and D.A. Fishman Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation Cancer Lett. 236 2006 292 301
77. N.E. Sounni, and A. Noel Membrane type-matrix metalloproteinases and tumor progression Biochimie 87 2005 329 342
78. M.A. Weaver Invadopodia: specialized cell structures of cancer invasion Clin. Exp. Metastasis 23 2006 97 105
79. H. Li, F. Lindenmeyer, C. Grenet, P. Opolon, S. Menashi, C. Soria, P. Yeh, M. Perricaudet, and H. Lu AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice Hum. Gene Ther. 12 2001 515 526
80. V. Krishnan, L.A. Shuman, D.M. Sosnoski, R. Dhurjati, E.A. Vogler, and A.M. Mastro Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures J. Cell. Physiol. 226 8 2011 2150 2158